Evaluate preclinical efficacy of anti alpha-synuclein an

Project: Research project

Project Details

Description

Evaluate preclinical efficacy of anti alpha-synuclein antibody treatment on the onset and progression of alpha-synucleinopathy in A53T mutant human alpha-synuclein transgenic mice.
StatusFinished
Effective start/end date11/7/177/31/18

Funding

  • ABL BIO

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.